While the predominant effects of p53 induction via EA have been reported to involve cell cycle arrest and the triggering of apoptosis, it remains a possibility that p53-induced alterations in cancer cell metabolism could also play a role in the antiproliferative effects of EA. The gene discussed is TP53; the disease is cancer.